Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Drug Product Manufacturing
  6.  » Drug Manufacturing in a Time of Coronavirus

Drug Manufacturing in a Time of Coronavirus

Summary: The COVID-19 pandemic has roiled R&D plans, created new priorities overnight and generally forced a major shift in many global manufacturing operations. This is an unprecedented time and we must work together to find innovative solutions at warp speed to beat COVID-19 and save lives.

In this webinar, John Carroll from Endpoints moderates a discussion between experts from Moderna, Sanofi Pasteur, Takeda and Catalent.

Click here to view the webinar